ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour.

February 1, 2012 by

February 1, 2012 by

January 1, 2012 by

January 1, 2012 by

January 1, 2012 by

January 1, 2012 by